1. Home
  2. BPTH vs FAMI Comparison

BPTH vs FAMI Comparison

Compare BPTH & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPTH
  • FAMI
  • Stock Information
  • Founded
  • BPTH 2007
  • FAMI 2015
  • Country
  • BPTH United States
  • FAMI China
  • Employees
  • BPTH N/A
  • FAMI N/A
  • Industry
  • BPTH Biotechnology: Pharmaceutical Preparations
  • FAMI Packaged Foods
  • Sector
  • BPTH Health Care
  • FAMI Consumer Staples
  • Exchange
  • BPTH Nasdaq
  • FAMI Nasdaq
  • Market Cap
  • BPTH 5.0M
  • FAMI 3.1M
  • IPO Year
  • BPTH N/A
  • FAMI 2018
  • Fundamental
  • Price
  • BPTH $1.09
  • FAMI $0.33
  • Analyst Decision
  • BPTH Strong Buy
  • FAMI
  • Analyst Count
  • BPTH 2
  • FAMI 0
  • Target Price
  • BPTH $30.00
  • FAMI N/A
  • AVG Volume (30 Days)
  • BPTH 6.2M
  • FAMI 330.4K
  • Earning Date
  • BPTH 11-15-2024
  • FAMI 01-27-2025
  • Dividend Yield
  • BPTH N/A
  • FAMI N/A
  • EPS Growth
  • BPTH N/A
  • FAMI N/A
  • EPS
  • BPTH N/A
  • FAMI 0.13
  • Revenue
  • BPTH N/A
  • FAMI $86,261,500.00
  • Revenue This Year
  • BPTH N/A
  • FAMI N/A
  • Revenue Next Year
  • BPTH N/A
  • FAMI N/A
  • P/E Ratio
  • BPTH N/A
  • FAMI $2.42
  • Revenue Growth
  • BPTH N/A
  • FAMI N/A
  • 52 Week Low
  • BPTH $0.59
  • FAMI $0.17
  • 52 Week High
  • BPTH $12.00
  • FAMI $2.35
  • Technical
  • Relative Strength Index (RSI)
  • BPTH 54.13
  • FAMI 57.99
  • Support Level
  • BPTH $1.11
  • FAMI $0.29
  • Resistance Level
  • BPTH $1.34
  • FAMI $0.34
  • Average True Range (ATR)
  • BPTH 0.30
  • FAMI 0.03
  • MACD
  • BPTH 0.02
  • FAMI 0.00
  • Stochastic Oscillator
  • BPTH 16.36
  • FAMI 82.87

About BPTH Bio-Path Holdings Inc.

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.

About FAMI Farmmi Inc.

Farmmi Inc is a supplier of agricultural products. The products of the company are Shiitake Mushroom, Mu Er Mushroom and other edible fungi and other agricultural products. The majority of products are sold in mainland China.

Share on Social Networks: